Four paths to partnership
Different partners. Different opportunities
Explore how Afromics works with biopharma, researchers, governments, and foundations — and find the right starting point for your organisation.
01For biopharma
Data Licensing & Trial Support
Afromics offers pharmaceutical and biotech partners licensed access to deeply phenotyped African genomic data.
- Recurring, per-partner, per-year licensing agreements — not one-off data sales
- Clinical trial site identification through our clinical partner network
- Patient pre-screening by genotype and pharmacogenomic profile
02For researchers
Academic Collaboration
Afromics partners with academic researchers through tiered data access, co-investigator agreements, and joint grant applications.
- Scientific leadership based in Cambridge and Imperial College London
- Actively building the UK Sickle Cell Research Collaborative Network
- New research collaborations aligned with our ten-year roadmap are welcome
03For governments
National Health Data Partnership
Afromics works with national governments to build sovereign genomic data infrastructure.
- Stored and processed within the continent, governed under national and African data jurisdiction
- Built to directly inform national health policy
- Ghana operations as the model: clinical site partnerships and ethics pathway alignment with national research councils
- Capacity-building commitment to local researchers and institutions
04For foundations
Grant Partnership
Afromics partners with philanthropic foundations across every phase of our ten-year roadmap.
- From Phase 1 infrastructure funding to named disease-area expansion programmes
- Full impact reporting and attribution
- Named programme partnerships within our public communications, where appropriate